Cargando…

Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis

PURPOSE: To explore the potential mechanism of glycosidic fraction of Picrorhiza scrophulariiflora Pennell (GPS) extract for the treatment of colitis using UPLC-QTOF-MS analysis, network pharmacology and experimental research. METHODS: The active components of GPS extract were identified by UPLC-QTO...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Peigen, Chang, Churui, Zhu, Guanglin, Zhai, Lixiang, Zhang, Xu, Huan, Qiuchan, Gao, Zhengxian, Deng, Huan, Liang, Yue, Xiao, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224697/
https://www.ncbi.nlm.nih.gov/pubmed/37249930
http://dx.doi.org/10.2147/DDDT.S407339
_version_ 1785050253644267520
author Wu, Peigen
Chang, Churui
Zhu, Guanglin
Zhai, Lixiang
Zhang, Xu
Huan, Qiuchan
Gao, Zhengxian
Deng, Huan
Liang, Yue
Xiao, Haitao
author_facet Wu, Peigen
Chang, Churui
Zhu, Guanglin
Zhai, Lixiang
Zhang, Xu
Huan, Qiuchan
Gao, Zhengxian
Deng, Huan
Liang, Yue
Xiao, Haitao
author_sort Wu, Peigen
collection PubMed
description PURPOSE: To explore the potential mechanism of glycosidic fraction of Picrorhiza scrophulariiflora Pennell (GPS) extract for the treatment of colitis using UPLC-QTOF-MS analysis, network pharmacology and experimental research. METHODS: The active components of GPS extract were identified by UPLC-QTOF-MS analysis and extracted their targets from the databases, which was used for network pharmacology analysis. Kyoto Encyclopedia of genes and genomes (KEGG) pathway analysis was performed to discover potential therapeutic mechanisms, and the network pharmacology results were then validated by in vivo and in vitro experiments. RESULTS: The results showed that GPS extract significantly alleviated the clinical signs of colitis, including body weight, disease activity index, colon shortening, and colon tissue damage, and inhibited the transcription and production of colonic IL-1β and IL-6 in DSS-induced colitis mice. In vitro, GPS extract also significantly suppressed nitric oxide (NO) production, iNOS expression, IL-1β and IL-6 transcription of LPS-activated RAW 264.7 cells. Network pharmacology integrated with experimental validation identified that GPS extract significantly suppressed Akt, p38, ERK, and JNK phosphorylation in vivo and in vitro, and luteolin, apocynin, caffeic acid, caffeic acid methyl ester, luteoloside, picroside II, aucubin, cinnamic acid, vanillic acid, and sweroside were the main components responsible for the anti-inflammatory effect of GPS. These findings demonstrate that the potential anti-inflammatory effect of GPS extract against colitis is achieved through suppressing PI3K/Akt and MAPK pathways, and that the abovementioned active components mainly exerted its anti-inflammatory effect. CONCLUSION: The therapeutic effect of GPS extract on colitis is related to PI3K/Akt and MAPK pathways, which is a promising remedy for colitis therapy.
format Online
Article
Text
id pubmed-10224697
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-102246972023-05-28 Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis Wu, Peigen Chang, Churui Zhu, Guanglin Zhai, Lixiang Zhang, Xu Huan, Qiuchan Gao, Zhengxian Deng, Huan Liang, Yue Xiao, Haitao Drug Des Devel Ther Original Research PURPOSE: To explore the potential mechanism of glycosidic fraction of Picrorhiza scrophulariiflora Pennell (GPS) extract for the treatment of colitis using UPLC-QTOF-MS analysis, network pharmacology and experimental research. METHODS: The active components of GPS extract were identified by UPLC-QTOF-MS analysis and extracted their targets from the databases, which was used for network pharmacology analysis. Kyoto Encyclopedia of genes and genomes (KEGG) pathway analysis was performed to discover potential therapeutic mechanisms, and the network pharmacology results were then validated by in vivo and in vitro experiments. RESULTS: The results showed that GPS extract significantly alleviated the clinical signs of colitis, including body weight, disease activity index, colon shortening, and colon tissue damage, and inhibited the transcription and production of colonic IL-1β and IL-6 in DSS-induced colitis mice. In vitro, GPS extract also significantly suppressed nitric oxide (NO) production, iNOS expression, IL-1β and IL-6 transcription of LPS-activated RAW 264.7 cells. Network pharmacology integrated with experimental validation identified that GPS extract significantly suppressed Akt, p38, ERK, and JNK phosphorylation in vivo and in vitro, and luteolin, apocynin, caffeic acid, caffeic acid methyl ester, luteoloside, picroside II, aucubin, cinnamic acid, vanillic acid, and sweroside were the main components responsible for the anti-inflammatory effect of GPS. These findings demonstrate that the potential anti-inflammatory effect of GPS extract against colitis is achieved through suppressing PI3K/Akt and MAPK pathways, and that the abovementioned active components mainly exerted its anti-inflammatory effect. CONCLUSION: The therapeutic effect of GPS extract on colitis is related to PI3K/Akt and MAPK pathways, which is a promising remedy for colitis therapy. Dove 2023-05-23 /pmc/articles/PMC10224697/ /pubmed/37249930 http://dx.doi.org/10.2147/DDDT.S407339 Text en © 2023 Wu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wu, Peigen
Chang, Churui
Zhu, Guanglin
Zhai, Lixiang
Zhang, Xu
Huan, Qiuchan
Gao, Zhengxian
Deng, Huan
Liang, Yue
Xiao, Haitao
Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis
title Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis
title_full Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis
title_fullStr Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis
title_full_unstemmed Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis
title_short Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis
title_sort network pharmacology study of bioactive components and molecular mechanisms of the glycoside fraction from picrorhiza scrophulariiflora against experimental colitis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224697/
https://www.ncbi.nlm.nih.gov/pubmed/37249930
http://dx.doi.org/10.2147/DDDT.S407339
work_keys_str_mv AT wupeigen networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis
AT changchurui networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis
AT zhuguanglin networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis
AT zhailixiang networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis
AT zhangxu networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis
AT huanqiuchan networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis
AT gaozhengxian networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis
AT denghuan networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis
AT liangyue networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis
AT xiaohaitao networkpharmacologystudyofbioactivecomponentsandmolecularmechanismsoftheglycosidefractionfrompicrorhizascrophulariifloraagainstexperimentalcolitis